Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
季节性流感血凝素(HA)DNA疫苗初免后接种三价流感灭活疫苗(IIV3)加强免疫的I期临床评估
期刊:Contemporary Clinical Trials
影响因子:1.9
doi:10.1016/j.cct.2015.08.006
Ledgerwood, Julie E; Hu, Zonghui; Costner, Pamela; Yamshchikov, Galina; Enama, Mary E; Plummer, Sarah; Hendel, Cynthia S; Holman, Lasonji; Larkin, Brenda; Gordon, Ingelise; Bailer, Robert T; Poretz, Donald M; Sarwar, Uzma; Kabadi, Alisha; Koup, Richard; Mascola, John R; Graham, Barney S